Cargando…

Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies

The role that mechanistic mathematical modeling and systems biology will play in molecular medicine and clinical development remains uncertain. In this study, mathematical modeling and sensitivity analysis were used to explore the working hypothesis that mechanistic models of human cascades, despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Luan, Deyan, Zai, Michael, Varner, Jeffrey D
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924874/
https://www.ncbi.nlm.nih.gov/pubmed/17658944
http://dx.doi.org/10.1371/journal.pcbi.0030142
_version_ 1782134223265595392
author Luan, Deyan
Zai, Michael
Varner, Jeffrey D
author_facet Luan, Deyan
Zai, Michael
Varner, Jeffrey D
author_sort Luan, Deyan
collection PubMed
description The role that mechanistic mathematical modeling and systems biology will play in molecular medicine and clinical development remains uncertain. In this study, mathematical modeling and sensitivity analysis were used to explore the working hypothesis that mechanistic models of human cascades, despite model uncertainty, can be computationally screened for points of fragility, and that these sensitive mechanisms could serve as therapeutic targets. We tested our working hypothesis by screening a model of the well-studied coagulation cascade, developed and validated from literature. The predicted sensitive mechanisms were then compared with the treatment literature. The model, composed of 92 proteins and 148 protein–protein interactions, was validated using 21 published datasets generated from two different quiescent in vitro coagulation models. Simulated platelet activation and thrombin generation profiles in the presence and absence of natural anticoagulants were consistent with measured values, with a mean correlation of 0.87 across all trials. Overall state sensitivity coefficients, which measure the robustness or fragility of a given mechanism, were calculated using a Monte Carlo strategy. In the absence of anticoagulants, fluid and surface phase factor X/activated factor X (fX/FXa) activity and thrombin-mediated platelet activation were found to be fragile, while fIX/FIXa and fVIII/FVIIIa activation and activity were robust. Both anti-fX/FXa and direct thrombin inhibitors are important classes of anticoagulants; for example, anti-fX/FXa inhibitors have FDA approval for the prevention of venous thromboembolism following surgical intervention and as an initial treatment for deep venous thrombosis and pulmonary embolism. Both in vitro and in vivo experimental evidence is reviewed supporting the prediction that fIX/FIXa activity is robust. When taken together, these results support our working hypothesis that computationally derived points of fragility of human relevant cascades could be used as a rational basis for target selection despite model uncertainty.
format Text
id pubmed-1924874
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-19248742007-07-26 Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies Luan, Deyan Zai, Michael Varner, Jeffrey D PLoS Comput Biol Research Article The role that mechanistic mathematical modeling and systems biology will play in molecular medicine and clinical development remains uncertain. In this study, mathematical modeling and sensitivity analysis were used to explore the working hypothesis that mechanistic models of human cascades, despite model uncertainty, can be computationally screened for points of fragility, and that these sensitive mechanisms could serve as therapeutic targets. We tested our working hypothesis by screening a model of the well-studied coagulation cascade, developed and validated from literature. The predicted sensitive mechanisms were then compared with the treatment literature. The model, composed of 92 proteins and 148 protein–protein interactions, was validated using 21 published datasets generated from two different quiescent in vitro coagulation models. Simulated platelet activation and thrombin generation profiles in the presence and absence of natural anticoagulants were consistent with measured values, with a mean correlation of 0.87 across all trials. Overall state sensitivity coefficients, which measure the robustness or fragility of a given mechanism, were calculated using a Monte Carlo strategy. In the absence of anticoagulants, fluid and surface phase factor X/activated factor X (fX/FXa) activity and thrombin-mediated platelet activation were found to be fragile, while fIX/FIXa and fVIII/FVIIIa activation and activity were robust. Both anti-fX/FXa and direct thrombin inhibitors are important classes of anticoagulants; for example, anti-fX/FXa inhibitors have FDA approval for the prevention of venous thromboembolism following surgical intervention and as an initial treatment for deep venous thrombosis and pulmonary embolism. Both in vitro and in vivo experimental evidence is reviewed supporting the prediction that fIX/FIXa activity is robust. When taken together, these results support our working hypothesis that computationally derived points of fragility of human relevant cascades could be used as a rational basis for target selection despite model uncertainty. Public Library of Science 2007-07 2007-07-20 /pmc/articles/PMC1924874/ /pubmed/17658944 http://dx.doi.org/10.1371/journal.pcbi.0030142 Text en © 2007 Luan et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Luan, Deyan
Zai, Michael
Varner, Jeffrey D
Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies
title Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies
title_full Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies
title_fullStr Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies
title_full_unstemmed Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies
title_short Computationally Derived Points of Fragility of a Human Cascade Are Consistent with Current Therapeutic Strategies
title_sort computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924874/
https://www.ncbi.nlm.nih.gov/pubmed/17658944
http://dx.doi.org/10.1371/journal.pcbi.0030142
work_keys_str_mv AT luandeyan computationallyderivedpointsoffragilityofahumancascadeareconsistentwithcurrenttherapeuticstrategies
AT zaimichael computationallyderivedpointsoffragilityofahumancascadeareconsistentwithcurrenttherapeuticstrategies
AT varnerjeffreyd computationallyderivedpointsoffragilityofahumancascadeareconsistentwithcurrenttherapeuticstrategies